Shawn Johnstone

Title: The Innovations of Shawn Johnstone

Introduction

Shawn Johnstone is an accomplished inventor based in Saint-Lazare, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various health conditions.

Latest Patents

Johnstone holds a patent for "Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same." This patent describes the crystalline and liquid crystalline forms of 25HC3S sodium, including Forms I, II, III, V, IX, XI, and XIII, as well as combinations thereof. The patent also details pharmaceutical formulations of these forms and methods for treating or preventing diseases such as hypercholesterolemia, hypertriglyceridemia, and conditions related to fat accumulation and inflammation, including non-alcoholic fatty liver disease (NAFLD) and atherosclerosis. Additionally, methods for preparing 25HC3S are provided.

Career Highlights

Johnstone is associated with Medicis Pharmaceutical Corporation, where he has been instrumental in advancing pharmaceutical innovations. His work has focused on developing effective treatments that address critical health issues.

Collaborations

Throughout his career, Johnstone has collaborated with notable colleagues, including Andrew R Miksztal and Michael Holtz-Mulholland. These collaborations have contributed to the success of his projects and the advancement of pharmaceutical research.

Conclusion

Shawn Johnstone's contributions to the field of pharmaceuticals through his innovative patent and collaborations highlight his commitment to improving health outcomes. His work continues to influence the development of effective treatments for various diseases.